Assenagon Asset Management
KROS icon

Assenagon Asset Management’s Keros Therapeutics KROS Stock Holding History

Assenagon Asset Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.35M Buy
101,297
+36,360
+56% +$485K ﹤0.01% 842
2025
Q1 		$662K Hold
64,937
– – ﹤0.01% 946
2024
Q4 		$1.03M Sell
64,937
-158,767
-71% -$2.51M ﹤0.01% 1076
2024
Q3 		$13M Buy
223,704
+199,245
+815% +$11.6M 0.02% 443
2024
Q2 		$1.12M Buy
+24,459
New +$1.12M ﹤0.01% 1052